August 27, 2012Open Access
View Full PaperIntraaortic Balloon Support for Myocardial Infarction with Cardiogenic Shock
Key Points
- The research aims to determine whether intraaortic balloon counterpulsation reduces 30-day mortality in patients with cardiogenic shock due to acute myocardial infarction.
- Randomized trial with early revascularization strategy planned for participants.
- Assessment of 30-day mortality outcomes.
- Trial registered under NCT00491036.
- No significant reduction in 30-day mortality was observed among patients receiving intraaortic balloon support.
Abstract
The use of intraaortic balloon counterpulsation did not significantly reduce 30-day mortality in patients with cardiogenic shock complicating acute myocardial infarction for whom an early revascularization strategy was planned. (Funded by the German Research Foundation and others; IABP-SHOCK II ClinicalTrials.gov number, NCT00491036.).